# Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse

Study · id `cardio:ct-nct01336348` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01336348](<https://clinicaltrials.gov/study/NCT01336348>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01336348

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 100 participants.

## Technical summary

Registry record NCT01336348. Randomized; single masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2011-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT01336348, source copy `cardio:ctgov-nct01336348-2012-10-10`, retrieved 2026-10-26)
- Start date: 2010-04 (registry gives no type) (ClinicalTrials.gov record NCT01336348, source copy `cardio:ctgov-nct01336348-2012-10-10`, retrieved 2026-10-26)
- Primary completion: 2011-06 (actual) (ClinicalTrials.gov record NCT01336348, source copy `cardio:ctgov-nct01336348-2012-10-10`, retrieved 2026-10-26)
- Completion: 2012-06 (actual) (ClinicalTrials.gov record NCT01336348, source copy `cardio:ctgov-nct01336348-2012-10-10`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT01336348, source copy `cardio:ctgov-nct01336348-2012-10-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01336348-2012-10-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse
- Acronym: FABOLUS PRO
- Condition: ST Segment Elevation Myocardial Infarction
- Intervention (Drug): Prasugrel
- Intervention (Drug): Tirofiban
- Lead sponsor: Università degli Studi di Ferrara
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry intervention name matches this record: Prasugrel (`cardio:prasugrel`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial (`cardio:pubmed-22440491`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 58a4356d85e4f5302f308d98855f8d360480e98d0732c06dfcd316f98274ffad
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
